Wharton jelly-derived mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Wharton jelly-derived mesenchymal stem cells, covering 2020-03-18 to 2020-03-18. Get the full timeline:
Most recent: Clinical Trial Update: WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS [Phase 2]